Zobrazeno 1 - 10
of 13
pro vyhledávání: '"B. E. Cantrell"'
Autor:
D. M. Zimmerman, S. W. Mascarella, Richard B. Rothman, Carroll Fi, Jim A. Thomas, B. E. Cantrell, Christina M. Dersch, Scott E. Fix
Publikováno v:
Journal of Medicinal Chemistry. 47:1070-1073
In vitro characterization and comparison of JDTic, its dehydroxy analogue and nor-BNI, and its dehydroxy analogue demonstrates that the N-substituted 3,4-dimethyl-(3-hydroxyphenyl)piperidine-derived antagonist, JDTic, relies more heavily on its pheno
Autor:
Jim A. Thomas, Robert N. Atkinson, D. M. Zimmerman, Noelle Vinson, Richard B. Rothman, Christina M. Dersch, Kenneth M. Gigstad, Nivedita Namdev, Scott E. Fix, Jason P. Burgess, Heng Xu, F. I. Carroll, S. W. Mascarella, B. E. Cantrell
Publikováno v:
Journal of Medicinal Chemistry. 45:3524-3530
A library of compounds biased toward opioid receptor antagonist activity was prepared by incorporating N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphans as the core scaffold using simultaneous solution phase synthetic methodology. From this lib
Autor:
Scott E. Fix, D. M. Zimmerman, S. W. Mascarella, James B. Thomas, Frank I. Carroll, Xiaoling Zheng, Jason P. Burgess, B. E. Cantrell, Lawrence E. Brieaddy
Publikováno v:
ChemInform. 29
Autor:
Frank I. Carroll, S. W. Mascarella, Richard B. Rothman, YF Lu, Heng Xu, D. M. Zimmerman, Noelle Vinson, James B. Thomas, Scott E. Fix, Robert N. Atkinson, B. E. Cantrell, Christina M. Dersch
Publikováno v:
Journal of medicinal chemistry. 44(17)
A structurally novel opioid kappa receptor selective ligand has been identified. This compound, (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JD
Autor:
David Bleakman, Paul L. Ornstein, Ken H. Ho, Baker, K.R Jarvie, B. E. Cantrell, Thomas J. Bleisch, Allan Mandelzys, Joseph P. Tizzano, Macklin Brian Arnold, Hamideh Zarrinmayeh, Michele Deverill, Rajender Kamboj, Richard Lee Simon, Mary Gates, D. M. Zimmerman
Publikováno v:
Journal of medicinal chemistry. 43(23)
Autor:
B. E. Cantrell
Publikováno v:
Landscape Journal. 28:134-135
Autor:
Julie B. Cooper, James B. Thomas, S. W. Mascarella, John S. Partilla, F. I. Carroll, B. E. Cantrell, Michael J. Fall, Christina M. Dersch, Heng Xu, K. B. Mccullough, D. M. Zimmerman, Richard B. Rothman
Publikováno v:
Journal of medicinal chemistry. 41(26)
A three-component library of compounds was prepared in parallel using multiple simultaneous solution-phase synthetic methodology. The compounds were biased toward opioid receptor antagonist activity by incorporating (+)-(3R,4R)-dimethyl-4-(3-hydroxyp
Autor:
Richard B. Rothman, John S. Partilla, J. L. Flippen-Anderson, D. M. Zimmerman, S. W. Mascarella, B. E. Cantrell, James B. Thomas, Christina M. Dersch, C. F. George, Frank I. Carroll, Xiaoling Zheng
Publikováno v:
Journal of medicinal chemistry. 41(21)
The inhibition of radioligand binding and [35S]GTPgammaS functional assay data for N-methyl- and N-phenethyl-9beta-methyl-5-(3-hydroxyphenyl)morphans (5b and 5c) show that these compounds are pure antagonists at the micro, delta, and kappa opioid rec
Autor:
S. W. Mascarella, Heng Xu, Frank I. Carroll, James B. Thomas, John S. Partilla, Richard B. Rothman, K. B. Mccullough, D. M. Zimmerman, B. E. Cantrell, Christina M. Dersch
Publikováno v:
Journal of medicinal chemistry. 41(11)
A study of the binding site requirements associated with the N-substituent of (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine (4) derivatives was undertaken using a set of rigid vs flexible N-substituents. The study showed that compounds 7-9 beari
Publikováno v:
The Journal of Organic Chemistry. 54:1442-1445